ExThera Medical and BioBridge Global Will Collaborate in Research Program to Apply ExThera’s Seraph® Microbind® Technology for Removal of Bacterial and Viral Threats to Global Blood Supply

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medical announced today that it is partnering with blood-banking leader BioBridge Global (San Antonio) in a research and development collaboration to evaluate new methods for the removal of bacteria and viruses from human banked blood and blood product, using ExThera’s broad-spectrum, biomimetic sorption hemoperfusion technology.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC